Chronic Myeloid Leukemia

Common Name(s)

Chronic Myeloid Leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myeloid Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myeloid Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Myeloid Leukemia" returned 1371 free, full-text research articles on human participants. First 3 results:

Second primary malignancies in chronic myeloid leukemia patients.
 

Author(s): Tugce Caliskan, Ahmet Emre Eskazan

Journal: J Cancer Res Ther. ;11(4):1042.

 

Last Updated: 17 Feb 2016

Go To URL
[Management of the cardiovascular disease risk during nilotinib treatment in chronic myeloid leukemia: 2015 recommendations from the France Intergroupe des Leucémies Myéloïdes Chroniques].
 

Author(s): Delphine Rea, Shanti Ame, Aude Charbonnier, Valérie Coiteux, Pascale Cony-Makhoul, Martine Escoffre-Barbe, Gabriel Etienne, Martine Gardembas, Agnès Guerci-Bresler, Laurence Legros, Franck Nicolini, Michel Tulliez, Eric Hermet, Françoise Huguet, Hyacinthe Johnson-Ansah, Simona Lapusan, Philippe Quittet, Philippe Rousselot, François-Xavier Mahon, Emmanuel Messas

Journal: Bull Cancer. 2016 Feb;103(2):180-9.

 

Tyrosine kinase inhibitors targeting the BCR-ABL oncoprotein represent an outstanding progress in chronic myeloid leukemia and long-term progression-free survival has become a reality for a majority of patients. However, tyrosine kinase inhibitors may at best chronicize rather than ...

Last Updated: 16 Feb 2016

Go To URL
Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.
 

Author(s): Ya-Zhen Qin, Qian Jiang, Hao Jiang, Yue-Yun Lai, Hong-Hu Zhu, Yan-Rong Liu, Bin Jiang, Xiao-Jun Huang

Journal: Medicine (Baltimore). 2016 Jan;95(2):e2486.

 

The aim of this study was to evaluate the impact of white blood cell (WBC) counts at presentation on the achievement of deep molecular response.A total of 362 newly diagnosed chronic-phase chronic myeloid leukemia patients (CML-CP) receiving 400 mg/day imatinib were serially monitored ...

Last Updated: 15 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Myeloid Leukemia" returned 146 free, full-text review articles on human participants. First 3 results:

Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
 

Author(s): L Wang, F Du, H-M Zhang, H-X Wang

Journal: Braz. J. Med. Biol. Res.. 2015 Jul;48(7):583-7.

 

We report the case of a father and son diagnosed with atypical chronic myeloid leukemia (aCML). Both patients harbored SETBP1 mutations, which are present in 24.3% of aCML patients. Moreover, both shared the variant encoding p.Pro737His, but the aCML severity was greater in the son ...

Last Updated: 9 Jul 2015

Go To URL
Diagnosing and managing advanced chronic myeloid leukemia.
 

Author(s): Michael W Deininger

Journal: Am Soc Clin Oncol Educ Book. 2015 ;():e381-8.

 

Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural history in the absence of effective therapy. Morphologically, transformation from CP-CML to AP/BP-CML is ...

Last Updated: 21 May 2015

Go To URL
Therapeutic drug monitoring of imatinib, nilotinib, and dasatinib for patients with chronic myeloid leukemia.
 

Author(s): Masatomo Miura

Journal: Biol. Pharm. Bull.. 2015 ;38(5):645-54.

 

Imatinib, nilotinib, and dasatinib are tyrosine kinase inhibitors (TKIs) that have become first-line treatments for Philadelphia chromosome-positive chronic myeloid leukemia (CML). According to European LeukemiaNet recommendations, the clinical response of CML patients receiving TKI ...

Last Updated: 7 May 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia
 

Status: Not yet recruiting

Condition Summary: Chronic Myelogenous Leukemia; Chronic Myeloid Leukemia; Leukemia

 

Last Updated: 15 Jun 2016

Go to URL
Bosutinib in Elderly Chronic Myeloid Leukemia
 

Status: Not yet recruiting

Condition Summary: Chronic Myeloid Leukemia

 

Last Updated: 20 Jun 2016

Go to URL
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
 

Status: Recruiting

Condition Summary: Chronic Phase Philadelphia Positive; BCR-ABL Positive; Chronic Myeloid Leukaemia

 

Last Updated: 13 Jun 2016

Go to URL